Paul Geertsema

9PUBLICATIONS
25CO-AUTHORS
Toxicology (incl. clinical toxicology)PainPharmacogenomicsNeonatologyCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 11, 2026
Measuring the Impact of tolvaptan-induced polyuria on quality of life in patients with autosomal dominant polycystic kidney disease.

|Aug 28, 2025
Results of a Multidisciplinary Stepwise Protocol to Treat Chronic Refractory Kidney-Related Pain.

Paul Geertsema, Ron T Gansevoort, Benjamin H J Doornweerd

|Mar 07, 2025
The long-term effect of tolvaptan treatment on kidney function and volume in patients with ADPKD.

Paul Geertsema, Thomas Bais, Vera Kuiken

|Jan 23, 2025
Nephrectomy in autosomal dominant polycystic kidney disease: a consensus statement of the ERA Genes & Kidney Working Group.

Paul Geertsema, Ron T Gansevoort, Mustafa Arici

|Feb 26, 2024
Validation of the Mayo Imaging Classification System for Predicting Kidney Outcomes in ADPKD.

Thomas Bais, Paul Geertsema, Martine G E Knol

|Nov 17, 2023
Higher beta-hydroxybutyrate ketone levels associated with a slower kidney function decline in ADPKD.

Martine G E Knol, Thomas Bais, Paul Geertsema

Pageof 2

Frequent Collaborators

4 joint publications

Ron T Gansevoort

4 joint publications

Martine G E Knol

2 joint publications

Thomas Bais

2 joint publications

Robbert J de Haas